Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Alves, M. Imrie, R. D. Gray, P. Nogueira, S. Ciordia, P. Pacheco, P. Azevedo, C. Lopes, A. Bugalho de Almeida, M. Guardiano, D. J. Porteous, J. P. Albar, A. C. Boyd, D. Penque (Lisbon, Porto, Portugal; Edinburgh, London, United Kingdom; Madrid, Spain). SELDI-TOF biomarkers signatures for cystic fibrosis, asthma and COPD. Eur Respir J 2009; 34: Suppl. 53, 858

Member's Comments

No comment yet.

Related content which might interest you: Proteomic analysis of sputum from adults with cystic fibrosis and COPD: identification of potential biomarkers for disease monitoring Source: Eur Respir J 2006; 28: Suppl. 50, 152s Year: 2006 New proteomic biomarkers of cystic fibrosis: a comparison with non-CF bronchiectasis Source: Eur Respir J 2005; 26: Suppl. 49, 240s Year: 2005 Differences in clinical features and biomarkers of subsequent acute cystic fibrosis pulmonary exacerbations - Analysing exacerbations as separate entities Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013 Application of omics technologies to the identification of biomarkers for COPD Source: Annual Congress 2007 - Cell biology of asthma and COPD Year: 2007 Metabolomic biomarkers predictive of early structural lung disease in cystic fibrosis Source: Eur Respir J 2016; 48: 1612-1621 Year: 2016 Pulmonary biomarkers in asthma and COPD Source: Annual Congress 2007 - PG13 - Outcome measures of clinical trials for new drugs for respiratory disease Year: 2007 Comparison of EBC biomarkers in cystic fibrosis and bacterial pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 191s Year: 2006 Inflammatory markers can predict pulmonary exacerbations of cystic fibrosis Source: International Congress 2017 – Cystic fibrosis: monitoring and biomarkers Year: 2017 Improved biomarkers of cystic fibrosis lung disease in bronchoalveolar lavage fluid identified using SELDI-TOF mass spectrometry Source: Eur Respir J 2004; 24: Suppl. 48, 213s Year: 2004 Differences in plasma and sputum biomarkers between COPD and COPD–asthma overlap Source: Eur Respir J 2014; 43: 421-429 Year: 2013 Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap Source: Annual Congress 2013 –Is it really asthma? Year: 2013 Proteomic analysis of plasma from COPD patients and smoking control subjects Source: Annual Congress 2007 - Novel therapeutic targets and disease markers in pulmonary pathology Year: 2007 Mass spectrometry proteomic biomarkers identify acute COPD exacerbations Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity Year: 2020 Differentiation of chronic obstructive pulmonary disease (COPD) including lung cancer from healthy control group by breath analysis using ion mobility spectrometry Source: Annual Congress 2011 - Clinical application of exhaled biomarkers Year: 2011 Phenotypic markers of asthma and COPD at the tissue level Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not? Year: 2005 Role of inflammatory biomarkers in COPD Source: International Congress 2016 – Systemic biomarkers Year: 2016 HRCT features in patients with severe asthma and non-cystic fibrosis bronchiectasis. Source: Virtual Congress 2020 – Air pollution and comorbidities Year: 2020 Inflammatuary markers in induced sputum and clinical parameters in children with non-cystic fibrosis bronchiectasis Source: Annual Congress 2004 - Chronic respiratory illness in childhood Year: 2004 Metabolomics identifies biomarkers of exacerbations in smokers with and without COPD Source: Virtual Congress 2020 – Inflammatory pathways in chronic airway diseases Year: 2020 The prognostic value of cardiac and inflammatory biomarkers in acute exacerbations of COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016